Real World Experience of Ustekinumab Therapy in Patients at a US Tertiary Inflammatory Bowel Disease Center

被引：0
|
作者：
Cleveland, Noa Krugliak [1 ]
Normatov, Inessa [1 ]
Buisson, Anthony [2 ]
Glick, Laura R. [3 ]
Zmeter, Nada [1 ]
Pekow, Joel [4 ]
Cohen, Russell [1 ]
Rubin, David T. [5 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ Chicago Med, Chicago, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-00679
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
679
引用
收藏
页码：S376 / S376
页数：1
相关论文
共 50 条
  • [1] Real World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center
    Dayan, Judy R.
    Dolinger, Michael
    Benkov, Keith
    Dunkin, David
    Jossen, Jacqueline
    Lai, Joanne
    Phan, Becky L.
    Pittman, Nanci
    Dubinsky, Marla C.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 69 (01): : 61 - 67
  • [2] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON USTEKINUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S25 - S26
  • [3] TACROLIMUS AS BRIDGE THERAPY FOR VEDOLIZUMAB AND USTEKINUMAB IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: EXPERIENCE AND OUTCOMES IN A TERTIARY CENTER IN SOUTH FLORIDA
    Gonzalez, Maria S. Lopez
    Zaidi, Zara
    Perez, Carla
    Crim, Alisa J. Muniz
    Oquendo, Luis F. Caicedo
    Felipez, Lina Maria
    GASTROENTEROLOGY, 2023, 164 (06) : S494 - S494
  • [4] Depression and Inflammatory Bowel Disease Patients: A Tertiary Care Center Experience
    Clark, Norman R.
    Horst, Sara N.
    Armstrong, Sharelle
    Gaines, Lawrence S.
    Duley, Caroline
    Wagnon, Julianne H.
    Rosenbury, Audra
    Ward, Jodie
    Schwartz, David A.
    Beaulieu, Dawn B.
    GASTROENTEROLOGY, 2011, 140 (05) : S784 - S784
  • [5] Experience with Ustekinumab and Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Data
    Kandemir, H.
    Karatas, A.
    Moral, K.
    Bilican, G.
    Kekilli, M.
    Cindoruk, M.
    Karakan, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1392 - i1393
  • [6] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    Advances in Therapy, 2023, 40 : 4421 - 4439
  • [7] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Bressler, Brian
    Jones, Jennifer
    In, Tracy S. H.
    Lan, Tommy
    Iconaru, Cristian
    Marshall, John K.
    ADVANCES IN THERAPY, 2023, 40 (10) : 4421 - 4439
  • [8] Immunosuppressive therapy in inflammatory bowel disease patients is associated with reactivation of Herpes Zoster: A tertiary center experience
    Sujaata, Dwadasi
    Dejan, Micic
    David, Rubin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S18 - S18
  • [9] Postoperative infectious complications in patients with Inflammatory Bowel Disease: experience of a tertiary center
    Librero Jimenez, M.
    Ortega Suazo, E. J.
    Sanchez Capilla, A. D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S463 - S464
  • [10] A retrospective case series of the use of ustekinumab in patients with inflammatory bowel disease at an Australian tertiary referral center
    Wark, K.
    Pavli, P.
    Subramaniam, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 151 - 152
12345